Abbvie names new General Managers for UK and France

pharmafile | June 2, 2017 | Appointment | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, appointment 

Abbvie has announced a double appointment across its UK and French operations, naming Jérôme Bouyer as its UK General Manager, UK, and Pierre-Claude Fumoleau succeeds him as General Manager, France.

Bouyer (pictured, right) joined Abbott/Abbvie in 2012 as General Manager of Belgium, before being promoted to his previous position as General Manager, France in 2014. Having worked as a Market Analyst for Bristol-Myers Squibb, Bouyer then served as a consultant for seven years and eventually joined Novartis. There he served in a range of roles across a number of countries, including Head of Business Operations & Strategic Planning for Region Europe in Basel; Head of Marketing & Specialty Products in Belgium; Specialty Business Unit Head in France; and Chief Marketing Officer for China, based in Shanghai.

Fumoleau (pictured, left) too served at BMS, starting at the company in 2000, working in a number of market and sales roles on a local and regional scale. Seven years later he joined Abbott, where he held the role of Commercial Director, Oncology, before leaving the company in 2008 to join AstraZeneca as Director of Business Unit Oncology. Returning to Abbott two years later, Fumoleau worked his way through a number of Director and General Manager roles. Prior to his latest appointment, he had served as General Manager AbbVie Norway since 2016.

Related Content

AbbVie to acquire ImmunoGen for approximately $10.1bn

AbbVie and ImmunoGen have announced that AbbVie will acquire ImmunoGen and its lead cancer therapy …

Aldeyra Therapeutics and AbbVie enter agreement for development and commercialisation of reproxalap

Aldeyra Therapeutics and AbbVie have announced that they have entered into an exclusive option agreement …


AbbVie’s Aquipta receives MHRA marketing authorisation

AbbVie has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted a …

Latest content